Evidence for the operation of both mechanisms of posttranscriptional regulation of IF1 expression has already been provided [6,15], thus emphasizing their potential contribution in the pathophysiology linked to IF1 expression

Evidence for the operation of both mechanisms of posttranscriptional regulation of IF1 expression has already been provided [6,15], thus emphasizing their potential contribution in the pathophysiology linked to IF1 expression. Not surprisingly, the overexpression of IF1 in hepatocarcinomas [20], bladder [21] and stomach [22] carcinomas and in gliomas [23] contributes, by different mechanisms, to cancer…

Read More

Peptide Receptors

Individual PC displays aberrant expression of ERK5, with significant upregulation of ERK5 protein in high-grade tumors [23]

Individual PC displays aberrant expression of ERK5, with significant upregulation of ERK5 protein in high-grade tumors [23]. acids and includes an N-terminal kinase domains (78C406 aa) and a distinctive C-terminal tail (410C816 aa), which harbors an autoinhibitory function [6]. The C-terminus also includes a myocyte enhancer aspect 2 (MEF-2)-interacting area (440C501 aa) [7], a nuclear…

Read More

Peptide Receptors

DC101 treatment increased mural cell coverage of tumor vessels, which could render the endothelium resistant to anti-angiogenic treatment

DC101 treatment increased mural cell coverage of tumor vessels, which could render the endothelium resistant to anti-angiogenic treatment. without affecting vessel regression and compromised the survival benefit of VEGFR2 inhibition by increasing vascular permeability. VEGFR2 inhibition normalized tumor vasculature while ectopic expression of Ang-2 diminished the beneficial effects of VEGFR2 blockade by inhibiting vessel normalization.…

Read More

Peptide Receptors